BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Holistic medicine
,
Acetaminophen
,
rs2476601
,
ERBB2
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Xarelto
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
The Net Clinical Outcome of Dual-Pathway Inhibition in Clinical Practice: The "Xarelto plus Acetylsa…
Design and baseline characteristics of the Xarelto Post-Authorization Safety & Effectiveness Study i…
Clear Instructions and Patient Education Key for Xarelto.
Rivaroxaban (Xarelto) - a new peripheral artery disease indication.
Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in P…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Alexa, What is Eliquis and Xarelto?
Xarelto Regulatory Post-Marketing Surveillance
Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Port…
Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan
Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ